<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pharmaceuticals-12-00147">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bissinger</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Fritsch</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mihut</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Genzel</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>W.-S.</given-names>
   </name>
   <name>
    <surname>Reichl</surname>
    <given-names>U.</given-names>
   </name>
  </person-group>
  <article-title>Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production</article-title>
  <source>Vaccine</source>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.04.054</pub-id>
 </element-citation>
</ref>
